05.01.26 -- STREAM Edition: Levers For Streamlining And Optimizing The Biosimilar Process

You understand the value of being able to test the manufacturability and scalability of your media formulation or to modify existing formulations to help drive cell culture performance. Learn more about our global cell culture media manufacturing network’s capabilities and equivalency strategies to help ensure on time, in full order fulfillment, reduced lead times, risk reduction, and the consistent, reliable quality you depend on. Watch now.

Advancing biologics requires confidence in safety, quality, and compliance. Learn how integrated analytical and biosafety testing, backed by decades of expertise, helps reduce risk.

See how a structured, scalable approach to process development can help improve productivity and maintain product quality.

 

New and more advanced production methods mean biosimilar developers can produce their own versions of commercial drugs with greater efficiency. Levers like cell line engineering and bioreactor controls make it easier to increase productivity.

Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges.

Explore how to choose between single‑use and stainless‑steel bioreactors, outlining key advantages, limitations, and long‑term considerations essential for successful biologics scale‑up.

Discover how manual precision at scale bridges packaging gaps, accelerates product launches, and ensures uninterrupted supply to deliver quality when automated equipment isn’t yet operational.